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Objectives: Nowadays, tuberculosis still becomes a major health problem in Asian country including Indonesia. The response of tuberculosis 
treatment is affected by many factors including Vitamin D receptor (VDR) gene polymorphism. Several polymorphism on VDR gene was reported in 
several studies responsible for treatment response or susceptibility to tuberculosis infection, one of which was FokI polymorphism. The distribution 
of FokI VDR genotype is highly affected by race and ethnicity. So far, there has been no study about this in Bali. Therefore, it is very important to 
conduct this study to identify the proportion of FokI VDR polymorphism in tuberculosis patients in Bali, Indonesia.
Methods: This study was a cross-sectional study. As many as, 35 subjects were selected from adult pulmonary tuberculosis patients who came to the 
pulmonary outpatient clinic of Sanglah Hospital, Bali. Analysis of FokI VDR polymorphism was using polymerase chain reaction/restriction fragment 
length polymorphism technique using restriction enzyme FokI.
Results: The proportion of FF, Ff, and ff genotype in this study was 20%, 54.3%, and 25.7%, respectively.
Conclusions: The dominant genotype of VDR in pulmonary tuberculosis patients in Bali was Ff.
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INTRODUCTION
According to the World Health Organization report, until 2013, there 
were 9 million new cases of tuberculosis and about 1.5 million died 
due to tuberculosis. In Indonesia, tuberculosis cases reached 5.8%, the 
third-highest cases in world following India and China [1-4].
Many factors might affect susceptibility to tuberculosis as well as 
tuberculosis therapeutic outcome, one of which was Vitamin D [5,6]. 
The role of Vitamin D on immunity and therapeutic response of 
tuberculosis was mediated by Vitamin D receptor (VDR). This can 
be affected by several factors, including polymorphism on VDR gene 
such as FokI polymorphism. Ethnicity and race were two factors most 
related to genetic variation [5,6]. Different countries with different 
ethnic or race might have different patterns of genetic variation, and the 
association between genetic variation and susceptibility or therapeutic 
response might different as well. Therefore, it was important to conduct 
research regarding distribution of FokI polymorphism of VDR gene on 
tuberculosis patients in Bali.
METHODS
Subjects for this study were including tuberculosis patients who 
attended Pulmonary Outpatient Clinic of Sanglah Hospital, Bali 
between June 2014 and December 2014. Subjects were selected using 
consecutive purposive sampling technique with minimum sample size 
32. The sample size was calculated based on the proportion of FokI 
polymorphism in Batak Indonesia on the previous study conducted 
by Sinaga et al. 0.092. The study design was cross-sectional study. This 
study was approved by Ethical Committee of Sanglah Hospital/Faculty 
of Medicine, Udayana University, Bali, Indonesia.
DNA was isolated using guanidine isothiocyanate methods. The 
sequence for forward primer of VDR was 5’-AGC TGG CCC TGG CAC 
TGA CTC TGG CTCT-3’ and for reverse primer of VDR was 5’-ATG GAA 
ACA CCT TGC TTC TTC TCC CTC-3’. DNA chains were denatured at 95°C 
for 5 min, followed by 35 cycles of reaction (95°C denaturation for 
1 min, 65°C annealing for 1 min, and 72°C elongation for 1 min), ended 
by a final extension at 72°C for 7 min. Polymerase chain reaction (PCR) 
products were digested using FokI restriction enzyme (New England 
Biolabs). Incubation was done at 37°C for 1 h. Electrophoresis of PCR-
restriction fragment length polymorphism product using 2% agarose 
gel. FF (wild type), Ff (heterozygote mutant), and ff (homozygote 
mutant) genotype of VDR showed one band (265 bp), three bands 
(265, 196, 69 bp), and two bands (196, 69 bp) on electrophoresis 
result, respectively.
RESULTS
Thirty-five tuberculosis patients were participated in our study. The 
baseline characteristics of subjects are shown in Table 1. FF (wild type), 
Ff (heterozygote mutant), and ff (homozygote mutant) genotype of 
VDR showed one band (265 bp), three bands (265, 196, 69 bp), and 
two bands (196, 69 bp) on electrophoresis result, respectively (Fig. 1).
Based on electrophoresis results, we found that the frequency 
and proportion of FF (wild type), Ff (heterozygote mutant), and ff 
(homozygote mutant) genotype of VDR were 7 (20%), 19 (54.3%), 
and 9 (25.7%). The frequency and proportion of allele F and f of VDR 
gene were 33 (47.1%) and 37 (52.9%). VDR FokI genotype patterns in 
tuberculosis patients based on age and sex are shown in Table 2.
DISCUSSION
Many factors might affect susceptibility to tuberculosis as well as 
tuberculosis therapeutic outcomes. Several factors contributing to 
the response of tuberculosis treatment such as age, genetic variation 
(related to drug-metabolizing enzymes), body mass index, severity 
of disease, previous treatment, comorbid disease (diabetes mellitus, 
cancer, and HIV/AIDS), albumin level, duration of tuberculosis 
treatment, concomitant treatment (immunosuppressive agents), 
Vitamin D, cigarette, and alcohol [2,7-11].
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Ethnicity and race were two factors most related to genetic variation. 
Different countries with different ethnic or race might have different 
patterns of genetic variations. Until now, there were four types of 
polymorphism which have been identified on VDR gene, including 
FokI, BsmI, TaqI, and ApaI polymorphism. Distribution of FokI alleles 
of VDR was vary in some populations. In our study, the proportion of 
allele F and f of VDR gene was 33 (47.1%) and 37 (52.9%), similar 
to the result of study conducted in Asian. Compare to other study; 
our study demonstrated higher proportion ofallele f of FokI VDR 
gene than those in Africa and Caucasia. The proportion of allele f of 
FokI VDR on African and Caucasian population was 24% and 34%, 
respectively [7,12]. Contrary to our result, the dominant allele in India 
was allele F. The proportion of allele F and f in India was 68.5% and 
31.5% [13].
In our study, the proportion of FF (wild type), Ff (heterozygote mutant), 
and ff (homozygote mutant) genotype of VDR was 20%, 54.3%, and 
25.7%, respectively. The majority of tuberculosis patients in Bali 
showed Ff genotype (heterozygote mutant) of VDR. Our result was 
similar to studies conducted in Chinese, Korean, and Indian population. 
Distribution of FF; Ff; and ff genotype was in China (34%; 45%; and 
21%), Korea (29%; 56%; and 14,6%), and India (44–46%; 42–49%; 
and 7–12%). Conversely, our study revealed different results with 
other studies conducted in Iran, Peru, and Indonesia (Batak ethnic). 
Distribution of FF; Ff; and ff genotype was in Iran (52–57%; 39%; and 
3–8%), Peru (9%; 32%; and 59%), and Indonesia Batak ethnic (36%; 
55%; and 9%) [6,12-17].
The association between VDR polymorphism and susceptibility to 
tuberculosis infection has been reported in many studies, but the result 
still inconsistent. A significant correlation between FokI polymorphism 
of VDR and tuberculosis risk was shown in study conducted by Wu et al. 
and Chen et al. [14,18]. Some meta-analysis studies also demonstrated 
similar results, such as study conducted by Sun and Cai, Huang et al., 
Sutaria et al., and Xu et al. [2,7,19,20].
In meta-analysis conducted by Sutaria et al., it was concluded that the 
role of VDR polymorphisms and tuberculosis risk varied in different 
populations. In Asian, genotype Bb and bb BsmI, ff FokI and Tt TaqI 
have proven to be significantly related to the increase of tuberculosis 
susceptibility, whereas ApaI genotype showed insignificant correlation. 
In European, only Bb and bb genotype of BsmI showed significant 
correlation to tuberculosis risk, whereas other polymorphisms did not 
show significant results. In African, all of the polymorphisms showed 
insignificant correlation with susceptibility to tuberculosis [2].
Besides the association with tuberculosis susceptibility, VDR 
polymorphisms have been known to related with tuberculosis 
therapeutic response. Otherwise studies about this still limited and the 
available studies showed inconsistent results. Study conducted in Peru 
concluded that VDR polymorphism was significantly related to time to 
culture conversion and time to conversion (on auramine staining) [6]. 
The conversion (on culture and auramine staining) was faster on FF 
genotype of FokI VDR than other genotypes of FokI VDR. This result was 
contradictive to study conducted by Junaid et al. The study conducted by 
Junaid et al. concluded that VDR polymorphism was not related to the 
response of tuberculosis treatment, especially in intensive phase that 
was assessed from time to sputum conversion [5]. Different from other 
studies, this study demonstrated insignificant correlation between VDR 
polymorphism and tuberculosis susceptibility [6].
The role of Vitamin D on immunity has been recognized for several 
years. The immunomodulatory effect of Vitamin D was related to the 
antimicrobial and anti-inflammatory activity of Vitamin D in many 
infectious diseases including tuberculosis. In case of tuberculosis, 
Vitamin D has been proven to increase eradication of Mycobacterium 
tuberculosis mediated by macrophage [2].
The effect of Vitamin D was mediated through VDR [21]. VDR was 
included in nuclear receptor family. Human VDR gene was located 
at chromosome 12q13.11. VDR gene was expressed in several 
types of immune cells, such as dendritic cells, T lymphocyte, and 
macrophage [4,14]. Genetical variation in VDR gene might cause change 
in Vitamin D activity.
Vitamin D, after activated into its active form, 1,25 dihydroxyvitamin 
D3 (1,25(OH)2D3) or calcitriol, subsequently would bind to VDR inside 
the macrophage. VDR located inside the cell. After binding to its 
receptor, this complex would interact with Vitamin D response elements 
and subsequently induced transcription of many target genes. In case 
of tuberculosis, Vitamin D will induce transcription of antimicrobial 
peptide cathelicidin (LL-37) for eliminating M. tuberculosis inside the 
phagolysosome [22].
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Fig. 1: Electrophoresis visualization of FokI Vitamin D receptor 
polymorphism. Sample no. 8 showed FF genotype (1 band, 
e.g., 265 bp). Sample no. 1, 2, 4, 5, 6, and 9 showed Ff genotype 
(3 bands, e.g., 265, 196, and 69 bp). Sample no. 3 and 7 showed ff 
genotype (2 bands, e.g., 196, and 69 bp). M: Marker
Table 1: Subject characteristics





<30 years old 16 (45.7)
≥30 years old 19 (54.3)
Table 2: Vitamin D receptor FokI genotype pattern in tuberculosis patients based on age and sex
Subjects characteristics FF genotype n (%) Ff genotype n (%) Ff genotype n (%) Total n (%)
Age
<30 years old 3 (18.8) 9 (56.2) 4 (25) 16 (100)
≥30 years old 4 (21.1) 10 (52.6) 5 (26.3) 19 (100)
Sex
Male 5 (25) 10 (50) 5 (25) 20 (100)
Female 2 (13.3) 9 (60) 4 (26.7) 15 (100)
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The certain mechanism of theanti-inflammatory effect of Vitamin D has 
not been established yet. The active VDR also affected the immune cell 
by inhibiting lymphocyte proliferation and decrease the production of 
proinflammatory cytokines to prevent excessive response [2]. Vitamin 
D has also been proven to have a direct effect on inflammatory response 
in vitro by inhibiting MAPK and NF-kB signaling. The inhibition of 
MAPK was related to the increased expression of MAPK phosphatase-1 
which defosforilated the active MAPK in human monocyte following 
the binding of 1,25(OH)2D3 to VDR.  Similarly,  the  inhibition  of NF-κB 
signaling was related to the increase of IκBα level (inhibitor of NF-κB) 
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